Eugene Garfield Economic Impact on Medical and Health Research Award
Garfield E. "The Origins of the Eugene Garfield Economic Impact of Medical and Health Research
Award". Inaugural Presentation. Award presented to Dr. David Meltzer. Philadelphia, July 10, 2002
Unpublished. No:497
2002 Eugene Garfield Economic Impact on Medical and Health Research
Award Winner
David Meltzer, MD, PhD
Eugene Garfield and David O. Meltzer at the Award Ceremony, 2002
David Meltzer, MD, PhD, was honored by Research!America in 2002 with the inaugural Eugene
Garfield Economic Impact of Medical and Health Research Award for his outstanding paper on
“Addressing Uncertainty in Medical Cost-effectiveness Analysis: Implications of Expected Utility
Maximization for Methods to Perform Sensitivity Analysis and the Use of Cost-effectiveness
Analysis to Set Priorities for Medical Research.”1A professor in the departments of medicine and economics at the University of Chicago, Meltzer accepted his award during a ceremony held at the GlaxoSmithKline headquarters in Philadelphia on July 10.The award is named in honor of its generous benefactor, Eugene Garfield, PhD. Garfield is the founder
of the science-citation indexing system—an indispensable tool used by scientists across many
research disciplines. He is the Founding Editor of The Scientist, a bi-weekly news journal for
life scientists; and a member of the Research!America Board of Directors.Meltzer was recognized for his work to merge the fields of economics and medicine. In publications such as the Journal of Health Economics, Meltzer developed unique methods to help decision makers use the tools of medical cost-effectiveness analysis to assess the potential benefits of biomedical research. Such methods could be used both to prioritize research projects and to help identify when further spending on research might be expected to yield substantial returns.
Reference :1. “Addressing Uncertainty in Medical Cost-effectiveness Analysis: Implications of Expected Utility
Maximization for Methods to Perform Sensitivity Analysis and the Use of Cost-effectiveness
Analysis to Set Priorities for Medical Research” Journal of Health Economics, 20(1):109-129, 2001.
